Academic Journal

P026 Chronic chilblain like lesions associated with the COVID-19 pandemic

Bibliographic Details
Title: P026 Chronic chilblain like lesions associated with the COVID-19 pandemic
Authors: Joseph A Nathan, Patrick Kiely
Source: Rheumatology. 62
Publisher Information: Oxford University Press (OUP), 2023.
Publication Year: 2023
Subject Terms: 03 medical and health sciences, 0302 clinical medicine, 3. Good health
Description: Background/Aims We report the features of chronic chilblain-like digital lesions newly presenting since the start of the covid-19 pandemic. Comparison with primary perniosis and acrocyanosis, reveals a unique phenotype which appears to be a long-covid phenomenon. Methods The case records of 26 patients with new onset persistent chilblain-like lesions presenting to the Rheumatology service of St George’s University Hospital, London between Autumn 2020 and Spring 2022 were reviewed. Demographic and clinical features, serology, imaging, treatment response and outcome up to Summer 2022 were collated retrospectively. Results Chilblain-like lesions first occurred between September and March; 2019/2020 6 cases, 2020/2021 18 cases and 2021/2022 2 cases. Mean age 35.4 (17-60) years, 88% female, 85% white, all non-smokers. Median body mass index (BMI) 20.2, range 17.0 - 33.2. BMI underweight ( Conclusion This series illustrates a distinct chronic chilblain-like condition. Features similar to primary perniosis include female predominance, middle age, pruritic painful blotchy lesions, asymmetry and low BMI. Features in keeping with acrocyanosis include chronicity, extensive diffuse erythro-cyanotic discoloration, relative improvement in warm weather and lack of association with smoking. Disclosure J.A. Nathan: None. P. Kiely: None.
Document Type: Article
Language: English
ISSN: 1462-0332
1462-0324
DOI: 10.1093/rheumatology/kead104.068
Rights: OUP Standard Publication Reuse
Accession Number: edsair.doi...........d922d1bf242fc40b751ef6f7b7c2c8ed
Database: OpenAIRE
Description
ISSN:14620332
14620324
DOI:10.1093/rheumatology/kead104.068